{
  "ticker": "IFT",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965837",
  "id": "02965837",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250704",
  "time": "0803",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250704/pdf/06lg3p5jbd4xh3.pdf",
  "summary": "### **Infratil Limited - CDC Independent Valuation (30 June 2025) - Material Information Summary**  \n\n- **Valuation Increase**: Infratil\u2019s 49.76% stake in CDC increased by **A$148M** (midpoint: **A$6.75B** vs. A$6.60B in March 2025).  \n- **Equity Valuation Decline**: CDC\u2019s 100% equity value decreased **1%** to **A$13.56B** (from A$13.70B), driven by higher assumed interest costs.  \n- **Capital Deployment**: Infratil acquired an additional **1.58% stake for A$220M**, increasing ownership to **49.76%**. Further **A$250M** commitment expected within 12 months.  \n- **Operational Update**:  \n  - **Added 54MW operational capacity** (Auckland), total operational capacity now **372MW**.  \n  - **Under construction**: **453MW** (up from 382MW), including expansions in Melbourne (+105MW) and Canberra (+19MW).  \n- **Valuation Methodology Shift**: Primary method changed to **DCF** (from Historical Transaction), with unchanged **cost of equity (11.05%)** and **terminal growth (2.5%)**.  \n\n*Omitted: Regional breakdowns, minor assumption adjustments, and non-material pipeline details.*",
  "usage": {
    "prompt_tokens": 1538,
    "completion_tokens": 296,
    "total_tokens": 1834,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-03T22:14:57.776859"
}